MedPath

Comparison of effectiveness of two medicines(sodium tetradecyl sulphate versus bleomycin)in the non-operative management of slow flow vascular malformations by sclerotherapy

Phase 3
Not yet recruiting
Conditions
Congenital malformation of peripheral vascular system, unspecified,
Registration Number
CTRI/2023/05/053122
Lead Sponsor
JAWAHARLAL NEHRU MEDICAL COLLEGE AND HOSPITAL JNMCH AMU ALIGARH UTTAR PRADESH
Brief Summary

I INTEND TO A RANDOMISED CONTROLLED TRIAL IN ORDER TO EVALUATE THE COMPARATIVE EFFICACY OF BLEOMYCIN VERSUS SODIUM TETRADECYL SULFATE IN TERMS OF OVERALL REDUCTION IN SIZE/VOLUME IN THE TREATMENT OF SLOW FLOW VASCULAR MALFORMATIONS

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria

ALL PATIENTS HAVING SLOW FLOW VASCULAR MALFORMATIONS AND REQUIRING TREATMENT AND GIVING CONSENT FOR SCLEROTHERAPY.

Exclusion Criteria

ALL PATIENTS HAVING SLOW FLOW VASCULAR MALFORMATIONS NOT REQUIRING TREATMENT OR NOT GIVING CONSENT FOR SCLEROTHERAPY.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
OVERALL REDUCTION IN SIZE/VOLUME AND VASCULARITY/FLOW RATE AFTER INTRA-LESIONAL SCLEROTHERAPY WITH SODIUM TETRADECYL SULFATE AND BLEOMYCINBASELINE, THEN 4-6 WEEKS AFTER FIRST SITTING, THEN 4-6 WEEKS AFTER SECOND SITTING
Secondary Outcome Measures
NameTimeMethod
SURGICAL OUTCOME AND THE EASE OF OPERABILITY IN CASE OPERATED24 MONTHS

Trial Locations

Locations (1)

JAWAHARLAL NEHRU MEDICAL COLLEGE AND HOSPITAL (JNMCH), A.M.U., ALIGARH

🇮🇳

Aligarh, UTTAR PRADESH, India

JAWAHARLAL NEHRU MEDICAL COLLEGE AND HOSPITAL (JNMCH), A.M.U., ALIGARH
🇮🇳Aligarh, UTTAR PRADESH, India
DR SAIFULLAH KHALID
Principal investigator
9897218098
saif2k2@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.